3ZR-26925-63437
2 vaccinations
1 coded response
13 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 531 / WI
- Registered
- 2022-09-19
- Relationship
- Child or adolescent in my care
- Guardian
- 9MW-25477-78424
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-08-25
Dose 1 — Pfizer-BioNTech
-
2022-09-19
Registered in v-safe
- 2022-09-19
- 2022-09-24
-
2022-09-26
Dose 2 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-30
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Unevaluable event — Feeling: Good · Site: Redness, Swelling/hardness · Fever · Irritability/cryingFree text: May be due to teethingMedDRA releases: 2024-11 · check-in free text available
- 2022-10-01
- 2022-10-02
- 2022-10-03
- 2022-10-10
- 2022-10-17
- 2022-10-24
- 2022-10-31
- 2022-11-07
- 2022-12-26
- 2023-03-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-08-25 | Pfizer-BioNTech | No |
| 2 | 2022-09-26 | Pfizer-BioNTech | Flu |
Free text
Release 12 (Under 3) — days 1–6 daily, dose 2, under 3
Systemic reaction (other): May be due to teething
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release